150 related articles for article (PubMed ID: 3060795)
1. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
Riou G; Barrois M; Sheng ZM; Duvillard P; Lhomme C
Oncogene; 1988 Sep; 3(3):329-33. PubMed ID: 3060795
[TBL] [Abstract][Full Text] [Related]
2. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
[TBL] [Abstract][Full Text] [Related]
3. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
[TBL] [Abstract][Full Text] [Related]
4. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
5. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
[TBL] [Abstract][Full Text] [Related]
6. [Presence of papillomavirus genomes and amplification of the c-myc and C-Ha-ras oncogenes in invasive cancers of the uterine cervix].
Riou G; Barrois M; Tordjman I; Dutronquay V; Orth G
C R Acad Sci III; 1984; 299(14):575-80. PubMed ID: 6097348
[TBL] [Abstract][Full Text] [Related]
7. Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma.
Ogata N; Kamimura T; Asakura H
Hepatology; 1991 Jan; 13(1):31-7. PubMed ID: 1846346
[TBL] [Abstract][Full Text] [Related]
8. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
9. ras mutations in human leukemia and related disorders.
Greenberger JS
Int J Cell Cloning; 1989 Nov; 7(6):343-59. PubMed ID: 2681441
[TBL] [Abstract][Full Text] [Related]
10. Detection of activated ras oncogenes in human thyroid carcinomas.
Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
[TBL] [Abstract][Full Text] [Related]
11. Proto-oncogenes and prognosis in early carcinoma of the uterine cervix.
Riou GF
Cancer Surv; 1988; 7(3):441-56. PubMed ID: 2853996
[TBL] [Abstract][Full Text] [Related]
12. Frequency of active ras oncogenes in human bladder cancers associated with schistosomiasis.
Fujita J; Nakayama H; Onoue H; Rhim JS; el-Bolkainy MN; el-Aaser AA; Kitamura Y
Jpn J Cancer Res; 1987 Sep; 78(9):915-20. PubMed ID: 3117747
[TBL] [Abstract][Full Text] [Related]
13. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
Mitra AB; Murty VV; Pratap M; Sodhani P; Chaganti RS
Cancer Res; 1994 Feb; 54(3):637-9. PubMed ID: 7905784
[TBL] [Abstract][Full Text] [Related]
14. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
[TBL] [Abstract][Full Text] [Related]
15. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the Kirsten-ras proto-oncogene in human preleukaemia.
Liu E; Hjelle B; Morgan R; Hecht F; Bishop JM
Nature; 1987 Nov 12-18; 330(6144):186-8. PubMed ID: 3313061
[TBL] [Abstract][Full Text] [Related]
18. [Studies on ras P21 expression and mutation at 12th codon of C-Ha-ras oncogene in squamous cell carcinoma of the larynx].
Yang Q
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(4):209-12, 251. PubMed ID: 8167038
[TBL] [Abstract][Full Text] [Related]
19. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
Weismanová E; Kalúz S; Skorvaga M
Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
[TBL] [Abstract][Full Text] [Related]
20. Activation of N-ras induced by ultraviolet irradiation in vitro.
Van der Lubbe JL; Rosdorff HJ; Bos JL; Van der Eb AJ
Oncogene Res; 1988; 3(1):9-20. PubMed ID: 3060800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
